Jonathan E. Lim
Chairman, CEO & Co-Founder
Collapse
Gary Yeung
CFO
David Chacko
Chief Business Officer
Wei Lin
Chief Medical Officer
Ebun Garner
General Counsel
Michael Varney
Chairman of R&D, SAB & Director
Jiangwen Majeti
GM, China & Head of Global Collaborations
Nik Chetwyn
SVP of Operations
Chandra Lovejoy
SVP of Regulatory Affairs
David Luo
VP of Clinical Research & Operations
Jean-Michel Vernier
VP of Chemistry
Les Brail
VP of Clinical Development
Robert Shoemaker
VP of Biology
Amanda Albert
VP of Portfolio & Program Leadership
Dawei Xuan
VP of Clinical Pharmacology
Jing Yi
VP of Data Science
Minli Xie
VP of Pharmaceutical Development & Operations
Board & Advisors
James A. Bristol
Director
Alexander W. Casdin
Director
Bihua Chen
Director
Julie Hambleton
Director
Val Harding
Director
Pratik S. Multani
Director
Bruce Roth
Senior Chemistry Advisor
Dave Matthews
Senior Crystallography Advisor
Greg Cosma
Senior Development Advisor
Paul Pearson
Senior ADME/PK Advisor
James Freddo
Senior Medical Advisor
Jane Chang
Senior Toxicology Advisor
Linda Robertson
Senior Regulatory Affairs Advisor